StockData
Renalytix plc logo

Renalytix plc (RNLXY) stock

RNLXYOTCServices-Medical LaboratoriesFiscal year ends June 30Also trades as RENXF
Số liệu tài chính tới Q1 năm tài chính 2025, quý kết thúc ngày Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$3.56+0.06 (+1.57%)

Close on Oct 19, 2026Market cap $375.75MP/E –Yield –

Renalytix operating margin

Operating margin is operating income as a percentage of revenue.

Renalytix's operating margin for the twelve months ending Sep 30, 2024 was -1054.9%. For fiscal 2024 it was -1293.5%, against -1240.7% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2024Jun 30, 2024-1293.5%−52.8
FY2023Jun 30, 2023-1240.7%+550.0
FY2022Jun 30, 2022-1790.7%+349.9
FY2021Jun 30, 2021-2140.6%–

Quarterly operating margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q1 FY2025CQ3 2024Sep 30, 2024-784.1%+1152.5
Q4 FY2024CQ2 2024Jun 30, 2024-942.8%+974.9
Q3 FY2024CQ1 2024Mar 31, 2024-1224.9%+283.0
Q2 FY2024CQ4 2023Dec 31, 2023-1218.8%−409.4
Q1 FY2024CQ3 2023Sep 30, 2023-1936.6%−726.9
Q4 FY2023CQ2 2023Jun 30, 2023-1917.8%−347.4
Q3 FY2023CQ1 2023Mar 31, 2023-1507.9%+282.4
Q2 FY2023CQ4 2022Dec 31, 2022-809.4%+821.6
Q1 FY2023CQ3 2022Sep 30, 2022-1209.7%+1241.3
Q4 FY2022CQ2 2022Jun 30, 2022-1570.4%+512.0
Q3 FY2022CQ1 2022Mar 31, 2022-1790.3%−486.4
Q2 FY2022CQ4 2021Dec 31, 2021-1631.0%+522.2
Q1 FY2022CQ3 2021Sep 30, 2021-2451.0%–
Q4 FY2021CQ2 2021Jun 30, 2021-2082.4%–
Q3 FY2021CQ1 2021Mar 31, 2021-1303.9%–
Q2 FY2021CQ4 2020Dec 31, 2020-2153.3%–

More Renalytix figures

See a number that looks wrong?